Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3033

Actual shortage: 243 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

29 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DARIFENACIN 7.5MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-12-15 2024-02-02 213547
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-26 214241
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-12 2024-03-22 215973
APO-FELODIPINE 2.5MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-19 2024-02-09 216662
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-22 216687
APO-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-03-05 216690
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-23 216693
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-04-19 216696
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-02-23 217300
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-26 2024-03-27 217481
APO-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-02 2024-02-23 218376
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-09 2024-04-19 219177
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS 100MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-23 2024-03-29 220465
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-01 2024-03-22 221096
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-08 2024-03-15 221717
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225770
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-19 2024-04-19 225779

Showing 2961 to 2980 of 3033

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
APO-BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60288
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2018-02-23 2019-09-12 40805
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2019-08-08 60420
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2018-09-08 2018-10-05 60717
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71201
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-DICLO 50MG TABLET (ENTERIC-COATED) Discontinued 2019-08-07 2019-08-07 91117
APO-DICLO SR 100MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4909
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Discontinued 2018-09-08 2018-09-15 60867

Showing 341 to 356 of 356